Shilpa Medicare Ltd - Company Profile
Powered by 
All the sales intelligence you need on Shilpa Medicare Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Shilpa Medicare Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Shilpa Medicare Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Shilpa Medicare Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4061333A4 | Search Report | Injizierbare zusammensetzungen von ursodeoxycholsäure | A61K31/575; A61K47/02; A61K47/40; A61K9/0019; A61K9/08 | December 06, 2023 |
| EP4081218A4 | Search Report | Oral auflösbare formulierungen von prucaloprid | A61K31/4525; A61K47/10; A61K47/26; A61K47/38; A61K47/40; A61K9/006; A61P1/00 | December 06, 2023 |
| US20230372238A1 | Application | Pharmaceutical suspension for oral dosage | A61K45/06; A61K47/02; A61K47/10; A61K47/12; A61K47/14; A61K47/34; A61K47/38; A61K9/0053 | November 23, 2023 |
| US11738020B2 | Grant | Stable liquid vigabatrin pharmaceutical composition for oral dosage | A61K31/197; A61K31/37; A61K31/403; A61K31/4045; A61K31/4178; A61K31/4725; A61K45/06; A61K47/12; A61K9/0095; A61P25/08 | August 29, 2023 |
| US20230263796A1 | Application | Pharmaceutical solution for oral dosage | A61K31/197; A61K31/37; A61K31/403; A61K31/4045; A61K31/4178; A61K31/4725; A61K45/06; A61K47/12; A61K9/0095; A61P25/08 | August 24, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer